Wells Fargo cuts Ionis Pharmaceuticals target price to $80 from $95
IONS•Wells Fargo cut its target price for Ionis Pharmaceuticals to $80 from $95.
Related News
SmartStop Self Storage REIT slips from record on nearly $302 million stock offering
SMA•
Urban One Q3 revenue falls, net loss widens on weak radio and digital demand
UONEK•
Olema Pharma Q3 net loss widens on higher costs
OLMA•
BioNTech to buy FDA priority review voucher from Scholar Rock for $205 million
SRRK•
Nurix Therapeutics participates in fireside chats at three investor conferences
NRIX•